Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis

Metformin, a well‐known antidiabetic drug, has been repurposed for cancer treatment; however, recently observed drug resistance and tumor metastasis have questioned its further application. Here, we found that long‐term metformin exposure led to metabolic adaptation of hepatocellular carcinoma (HCC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Ping, Jiang, Jingwen, Zhou, Li, Huang, Zhao, Qin, Siyuan, Chen, Hai‐Ning, Peng, Liyuan, Zhang, Zhe, Li, Bowen, Luo, Maochao, Zhang, Tingting, Ming, Hui, Ding, Ning, Li, Lei, Xie, Na, Gao, Wei, Zhang, Wei, Nice, Edouard C, Wei, Yuquan, Huang, Canhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728056/
https://www.ncbi.nlm.nih.gov/pubmed/36321555
http://dx.doi.org/10.15252/emmm.202216082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728056/
https://www.ncbi.nlm.nih.gov/pubmed/36321555
http://dx.doi.org/10.15252/emmm.202216082

Ejemplares similares